The bone scan as a tumour marker in prostatic carcinoma

Area of Science:

• Nuclear Medicine
• Oncology
• Radiology

Background:

• Prostate carcinoma frequently metastasizes to bone.
• Accurate detection and monitoring of bone metastases are crucial for patient management.

Purpose of the Study:

• To evaluate the utility of technetium methylene diphosphate bone scans in diagnosing and monitoring bone metastases in patients with prostate carcinoma.

Main Methods:

• A prospective study of 100 new patients with prostate carcinoma.
• Technetium methylene diphosphate bone scans were performed at initial diagnosis and serially.
• Results were compared with skeletal X-rays and serum acid phosphatase levels.

Main Results:

• 48% of patients had positive bone scans at initial diagnosis.
• Bone scans identified metastases in 23% of patients with negative X-rays.
• Serial bone scans demonstrated higher sensitivity than X-rays or serum acid phosphatase for disease progression.

Conclusions:

• Technetium methylene diphosphate bone scans are valuable for detecting bone metastases in prostate cancer.
• Bone scans serve as a reliable tumor marker for monitoring metastatic disease course.